Literature DB >> 6190489

Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia.

F F Foldes, H Nagashima, M Boros, E Tassonyi, S Fitzal, S Agoston.   

Abstract

The neuromuscular effects of three new nondepolarizing neuromuscular blocking drugs, atracurium, vecuronium and Duador, were investigated in surgical patients under balanced anaesthesia. (The numbers of patients in each study are given in the tables.) There were no significant differences in the neuromuscular effects of the three agents. None showed any cumulation after repeated administration of maintenance doses. Muscular relaxation for upper abdominal surgery was adequate as long as the isometric twitch tension (P) was no more than 25% of control. Conditions for tracheal intubation were satisfactory within less than 3 min after the start of injection. Spontaneous recovery of P to 90-95% of control, after the last dose of neuromuscular blocker was the fastest with vecuronium (35.8 +/- 2.4 min) and about the same with atracurium (54.3 +/- 2.4 min) and Duador (54.2 +/- 4.7 min). The T4/T1 ratio at the time of greater than 90% recovery of P was 0.44, 0.52 and 0.56 with vecuronium, Duador and atracurium, respectively, indicating the need for the reversal of the residual neuromuscular block. This could be accomplished within 2 min by the i.v. injection of edrophonium 0.5 mg kg-1, preceded by atropine 0.01 mg kg-1. No side-effects were observed with vecuronium. Atracurium caused mild to moderate histamine release in four of 50 patients included in this study, all of whom received an initial dose of 0.5 mg kg-1. The initial dose of Duador caused a 16.7% increase in heart rate. The findings indicate that the three new muscle relaxants merit further clinical trial. In our opinion, until the results of such studies become available, atracurium should not be used in patients with a history of allergic diathesis and Duador in those in whom increased heart rate may be harmful.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190489

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  8 in total

Review 1.  A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.

Authors:  R R Jaklitsch; D R Westenskow
Journal:  J Clin Monit       Date:  1990-01

2.  The effects of atracurium on intraocular pressure during steady state anaesthesia and rapid sequence induction: a comparison with succinylcholine.

Authors:  G G Lavery; J N McGalliard; R K Mirakhur; W F Shepherd
Journal:  Can Anaesth Soc J       Date:  1986-07

Review 3.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

4.  Atracurium and severe hepatic disease: a case report.

Authors:  H K Gyasi; M Naguib
Journal:  Can Anaesth Soc J       Date:  1985-03

5.  Use of atracurium in a patient with plasma cholinesterase deficiency.

Authors:  N Donen
Journal:  Can J Anaesth       Date:  1987-01       Impact factor: 5.063

6.  A comparison of computer-controlled versus manual administration of vecuronium in humans.

Authors:  R R Jaklitsch; D R Westenskow; N L Pace; J B Streisand; K A East
Journal:  J Clin Monit       Date:  1987-10

7.  Presynaptic effect of muscle relaxants on the release of 3H-norepinephrine controlled by endogenous acetylcholine in guinea pig atrium.

Authors:  F F Földes; O Kobayashi; M Kinjo; L G Harsing; H Nagashima; D Duncalf; P L Goldiner; E S Vizi
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

8.  Neuromuscular blockade with atracurium besylate in a patient with myasthenia gravis.

Authors:  D F Murphy; J B Magner
Journal:  Ir J Med Sci       Date:  1986-06       Impact factor: 1.568

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.